E. Stewart Geary,
MD
Senior VP, Chief Medical Officer, Director, Corporate Medical Affairs HQ, Eisai Co., Ltd.
(Edward) Stewart Geary, MD, serves as Senior Vice President, Chief Medical Officer, and Director, Corporate Medical Affairs Headquarters, for Eisai Co., Ltd., in Tokyo (Japan). He began his career at Eisai in oversight of international pharmacovigilance, including negotiation of all pharmacovigilance contracts; he subsequently assumed responsibility for the company’s global pharmacovigilance and regulatory affairs strategy and management. Dr. Geary’s professional memberships include the Japanese Association of Pharmaceutical Medicine, the IFAPP Executive Committee, the Council for Education in Pharmaceutical Medicine, the Regulations Advisory Board for the CMR International Institute for Regulatory Science, the American Academy of Pharmaceutical Physicians, the American Urological Association, the CIOMS Working Group on Standardized MedDRA Queries, and the International Advisory Board for ICPM2004, Geneva, Switzerland. He graduated Summa Cum Laude with a Bachelor’s degree in Chemistry from Harvard College, and earned his medical degree from the Stanford University School of Medicine.
Fellows of DIA
-
Tatsuo Kurokawa,
PhD •Chair, Fellows of DIA
President, Japan Self-Medication Industry -
Martin Harvey Allchurch • Principal International Affairs Officer, European Medicines Agency, European Union
-
Minnie Baylor-Henry,
JD • President, B-Henry & Associates -
Gaby Danan,
MD, PhD • Pharmacovigilance Expert -
Richard Day,
MD • Professor of Clinical Pharmacology, St. Vincent's Hospital -
Marie Dray,
MBA • President, International Regulatory Affairs Group LLC -
Nancy A. Dreyer,
MPH, PhD • Global Chief, Sci Affairs; Sr VP, Head, Center for Advanced Evidence Generation
IQVIA -
Ron Fitzmartin,
PhD • Senior Advisor, Strategic Programs,Center for Drug Evaluation and Research, US Food and Drug Administration -
E. Stewart Geary,
MD • Senior VP, Chief Medical Officer, Director, Corporate Medical Affairs HQ, Eisai Co., Ltd. -
Ken Getz,
MBA • Chairman, CISCRP; Director of Sponsored Research, Tufts Center For the Study of Drug Development -
Alberto Grignolo,
PhD • Corporate Vice President
PAREXEL International -
Yves Juillet,
MD • Senior Vice-President, Industrie Sante -
Sandra L. Kweder,
MD • Deputy Director, FDA Liaison to the EMA, Office of International Programs, OC -
Murray M. Lumpkin,
MD • Deputy Director, Integrated Delivery, and Lead for Global Regulatory Systems Initiatives
Bill and Melinda Gates Foundation -
Sandra A. Milligan,
MD, JD • Senior Vice President, Head of Global Regulatory Affairs and Clinical Safety, Merck & Co., Inc. -
Noriaki Murao,
MS • Representative, NM Consulting -
Jennifer Riggins,
PhD • Advisor, Digital Channels and eCapabilities, Eli Lilly and Company -
Jeffrey Sherman,
MD • Chief Medical Officer & EVP, Horizon Pharma, Inc. -
Per Spindler,
DVM, MBA • Director Biopeople, University of Copenhagen -
Ling Su,
PhD • Professor and Director, Institute of Drug Regulatory Science, Shenyang Pharmaceutical University, Venture Partner, Lilly Asia Ventures